About biomega
biomega is a Healthcare company based in Bergen (Norway) founded in 2002, and was acquired by AMERRA in March 2017. Peptides and hydrolyzed proteins for pet health are supplied. It operates on a Direct-to-Consumer (D2C) and B2B2C model. biomega offers products and services including SalMe Salmon Oil, Salmigo Active, Salmigo Salmon Oil, Salmigo Protect L60, and Aquaculture Feed Ingredients. Its focus areas include Food & Beverage, Functional Ingredients and Nutritional Supplements. Its legal entity is Biomega Group AS.
Company details
biomega is involved in the production of premium salmon-based ingredients for human and animal nutrition markets. Operations are focused on the blue economy with a circular approach to biorefining. Products are developed for health, pet food, and aquaculture sectors. Sustainability is emphasized through reducing, reusing, recycling, rethinking, and refusing strategies in supply chain processes. Facilities are located in Norway and Denmark, serving global markets across EMEA, the Americas, and Asia.
- Headquarters Bergen, Norway
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website biomegagroup.com
- Social LinkedIn
- Acquired by AMERRA (Mar 2017)
- Legal Name Biomega Group As
- Net Profit-$1.84 M (USD)-103as on Dec 31, 2022
- Latest Funding Round$3.41M (USD), Grant
Sep 2022
- InvestorsEuropean Union
& 1 more
- Acquired byAMERRA
(Mar 2017)
Products & Services of biomega
biomega offers a comprehensive portfolio of products and services, including SalMe Salmon Oil, Salmigo Active, Salmigo Salmon Oil, Salmigo Protect L60, and Aquaculture Feed Ingredients.
Salmon oil is produced for human nutrition markets.
High-protein product is made for pet food nutrition.
Salmon oil is crafted for premium pet food.
Protein powder is developed for pet food industry.
High-quality ingredients are produced for aquaculture feed.
Funding Insights of biomega
- Total Rounds 1
- Last Round Grant — $3.41M
- First Round $3.41M
(Sep 2022)
- Investors Count 1
All 1 funding rounds of biomega with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $3.41M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in biomega
biomega has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and AMERRA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Alternative asset management firm | 2009 | amerracapital.com | New York, United States |
Investor details for biomega
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of biomega
3 dated milestones of biomega across 20 years, from founding to its latest funding, stage changes and deals.
- Founded biomega is founded.
- Exit Acquired by AMERRA.
- Funding First funding round of $3.4M.
Web traffic of biomega
The website of biomega (biomegagroup.com) receives about 4.9K visits a month.
- Monthly visits4.9K
▲ 22.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biomega
Complete news archive for biomega
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about biomega
biomega was founded in 2002 and raised its 1st funding round 20 years after it was founded.
biomega is headquartered in Bergen, Norway. It is registered at Bergen, Vestland, Norway.
biomega is involved in the production of premium salmon-based ingredients for human and animal nutrition markets. Operations are focused on the blue economy with a circular approach to biorefining. Products are developed for health, pet food, and aquaculture sectors. Sustainability is emphasized through reducing, reusing, recycling, rethinking, and refusing strategies in supply chain processes. Facilities are located in Norway and Denmark, serving global markets across EMEA, the Americas, and Asia.
biomega offers SalMe Salmon Oil, Salmigo Active, Salmigo Salmon Oil, Salmigo Protect L60, and Aquaculture Feed Ingredients.
biomega has 2 investors. Key investors include European Union, and AMERRA.
biomega operates through Biomega Group As.
Yes. biomega was acquired by AMERRA in March 2017.